News
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy
Researchers identify a novel genetic cause of Fuchs endothelial corneal dystrophy, offering new ways for future therapies to target this common, age-related cause of visual loss. In a landmark study, researchers supported by NIHR Moorfields Biomedical Research Centre, have identified...
Hope for young children with impaired eye sight caused by Albinism
The University of Southampton has been awarded over half a million pounds for groundbreaking research aimed at improving the vision of children born with Albinism. Albinism affects the production of melanin – pigment which colours eyes, skin and hair. It...
The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....
ABDO announces groundbreaking therapy for contact lens opticians
The Association of British Dispensing Opticians (ABDO) has given the go ahead for contact lens opticians to prescribe a groundbreaking new therapy, enabling ~1,700 new practitioners to offer the treatment to their patients. NuVision Biotherapies, a UK based tissue-therapy company...
NYU Langone Health performs world’s first whole-eye & partial-face transplant
Landmark whole-eye transplant is a major paradigm shift for potential vision therapies.
